We are live on
!
Find out more
CCM
Chiron Capital Management Portfolio holdings
AUM
$97.5M
This Fund
S&P 500
This Quarter
Est. Return
-4.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.5M
AUM Growth
–
Cap. Flow
+$102M
Cap. Flow
% of AUM
105.03%
Top 10 Holdings %
Top 10 Hldgs %
37.77%
Holding
117
New
117
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$11.2M |
| 2 |
NVIDIA
NVDA
|
+$4.68M |
| 3 |
Microsoft
MSFT
|
+$4.61M |
| 4 |
Adobe
ADBE
|
+$3.5M |
| 5 |
Apple
AAPL
|
+$2.73M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.26% |
| 2 | Healthcare | 24.38% |
| 3 | Consumer Staples | 8.39% |
| 4 | Consumer Discretionary | 7.44% |
| 5 | Communication Services | 7.4% |
Similar funds
BFA
RM
BJB
JKSF
VIM
BWM
CFG
UWM
Chiron Capital Management's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Chiron Capital Management, which disclosed 117 positions worth $97.5M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Bristol-Myers Squibb: 191,288 shares worth $11.6M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, followed by Healthcare and Consumer Staples.
- Chiron Capital Management's largest Q1 2026 buy was Bristol-Myers Squibb: 191,288 shares worth $11.6M.
- Chiron Capital Management's ten largest holdings make up 38% of its $97.5M portfolio in Q1 2026.
- Chiron Capital Management disclosed 117 positions in Q1 2026, its first 13F filing on record.
Based on Chiron Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.